NGVT (Ingevity) Change In Payables And Accrued Expense : $-99 Mil (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Ingevity Change In Payables And Accrued Expense?

Ingevity's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was $-37 Mil. It means Ingevity's Accounts Payable & Accrued Expense declined by $37 Mil from Jun. 2024 to Sep. 2024 .

Ingevity's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-56 Mil. It means Ingevity's Accounts Payable & Accrued Expense declined by $56 Mil from Dec. 2022 to Dec. 2023 .

Ingevity Change In Payables And Accrued Expense Historical Data

The historical data trend for Ingevity's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ingevity Change In Payables And Accrued Expense Chart

Ingevity Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-26.50

19.50

42.70

48.90

-55.80

Ingevity Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-8.80	-48.70	-9.40	-4.30	-36.70

Ingevity Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-99 Mil.

Ingevity Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ingevity's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ingevity Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ingevity Corp (NYSE:NGVT) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

IGX:Germany

Address

4920 O'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405

Website

https://www.ingevity.com

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Executives

Christine Stunyo	officer: SVP, Chief HR Officer	4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
White Richard Allen Jr	officer: SVP, Perf Chem and Pres, ISPT	4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405
Phillip John Platt	officer: VP, CAO & Corporate Controller	5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Woodcock Stuart Edward Jr.	officer: EVP, President Perf Materials	5255 VIRGINIA AVE, NORTH CHARLESTON SC 29406
Bruce D. Hoechner	director	2225 W CHANDLER BLVD, CHANDLER AZ 85224
Erik Spencer Ripple	officer: Chief Growth & Innov Officer	4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
Benjamin G. Wright	director	4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON SC 29405
William J Slocum	director	C/O INCLUSIVE CAPITAL PARTNERS, L.P., 1170 GORGAS AVENUE, SAN FRANCISCO CA 94129
J Michael Fitzpatrick	director	C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612-4662
Diane H. Gulyas	director	C/O EXPEDITORS, 1015 THIRD AVENUE, SEATTLE WA 98104
Jean S Blackwell	director
Frederick J Lynch	director	C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Luis M Fernandez-moreno	director	ASHLAND INC., 8145 BLAZER DRIVE, WILMINGTON DE 19808
Karen G Narwold	director	ALBEMARLE CORPORATION, 4250 CONGRESS ST, SUITE 900, CHARLOTTE NC 28209
Steven Paul Hulme	officer: SVP, Perf Chem and Pres, EP	4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON SC 29405